Difference between revisions of "LncRNAWiki:Nervous System Diseases"
| Line 5: | Line 5: | ||
|- | |- | ||
|Alzheimer's disease | |Alzheimer's disease | ||
| − | |''SNHG3'', ''LINC01616'', ''LINC01080'', ''BACE1-AS'', ''BCYRN1'', ''HAR1A'', ''SOX2-OT'', ''LINC01772'' | + | |''[[SNHG3]]'', ''[[LINC01616]]'', ''[[LINC01080]]'', ''[[BACE1-AS]]'', ''[[BCYRN1]]'', ''[[HAR1A]]'', ''[[SOX2-OT]]'', ''[[LINC01772]]'' |
|- | |- | ||
|dermatomyositis | |dermatomyositis | ||
| − | |''7SL'' | + | |''[[7SL]]'' |
|- | |- | ||
|Down syndrome | |Down syndrome | ||
| − | |''DSCR4'', ''DSCR8'' | + | |''[[DSCR4]]'', ''[[DSCR8]]'' |
|- | |- | ||
|Duchenne muscular dystrophy | |Duchenne muscular dystrophy | ||
| − | |''LINCMD1'' | + | |''[[LINCMD1]]'' |
|- | |- | ||
|facioscapulohumeral muscular dystrophy | |facioscapulohumeral muscular dystrophy | ||
| − | |''DBET'' | + | |''[[DBET]]'' |
|- | |- | ||
|Huntington's disease | |Huntington's disease | ||
| − | |''HAR1A'', ''TUG1'', ''MEG3'', ''NOP14-AS1'', ''HTT-AS'', ''BDNF-AS'', ''HAR1B'' | + | |''[[HAR1A]]'', ''[[TUG1]]'', ''[[MEG3]]'', ''[[NOP14-AS1]]'', ''[[HTT-AS]]'', ''[[BDNF-AS]]'', ''[[HAR1B]]'' |
|- | |- | ||
|ischemic stroke | |ischemic stroke | ||
| − | |''CDKN2B-AS1'' | + | |''[[CDKN2B-AS1]]'' |
|- | |- | ||
|multiple sclerosis | |multiple sclerosis | ||
| − | |''IFNG-AS1'' | + | |''[[IFNG-AS1]]'' |
|- | |- | ||
|myotonic dystrophy | |myotonic dystrophy | ||
| − | |''DM1-AS'' | + | |''[[DM1-AS]]'' |
|- | |- | ||
|narcolepsy | |narcolepsy | ||
| − | |''LINC00165'' | + | |''[[LINC00165]]'' |
|- | |- | ||
|neural tube defects | |neural tube defects | ||
| − | |''H19'' | + | |''[[H19]]'' |
|- | |- | ||
|neurodevelopmental syndromes | |neurodevelopmental syndromes | ||
| − | |''SOX2-OT'' | + | |''[[SOX2-OT]]'' |
|- | |- | ||
|Parkinson's Disease | |Parkinson's Disease | ||
| − | |''MAPT-AS1'' | + | |''[[MAPT-AS1]]'' |
|- | |- | ||
|Prader-Willi syndrome | |Prader-Willi syndrome | ||
| − | |''MKRN3-AS1'', ''SNHG14'', ''PWRN1'', ''PWRN2'', ''IPW'', ''PWARSN'', ''MKRN3-AS1'', ''H19'', ''MEG8'' | + | |''[[MKRN3-AS1]]'', ''[[SNHG14]]'', ''[[PWRN1]]'', ''[[PWRN2]]'', ''[[IPW]]'', ''[[PWARSN]]'', ''[[MKRN3-AS1]]'', ''[[H19]]'', ''[[MEG8]]'' |
|- | |- | ||
|psychiatric disease | |psychiatric disease | ||
| − | |''BDNF-AS'' | + | |''[[BDNF-AS]]'' |
|- | |- | ||
|spinocerebellar ataxia | |spinocerebellar ataxia | ||
| − | |''SCAANT1'', ''ATXN8OS'' | + | |''[[SCAANT1]]'', ''[[ATXN8OS]]'' |
|- | |- | ||
|syndromic developmental defect | |syndromic developmental defect | ||
| − | |''MIR17HG'' | + | |''[[MIR17HG]]'' |
|- | |- | ||
|Usher syndrome type 3 | |Usher syndrome type 3 | ||
| − | |''CLRN1-AS1'' | + | |''[[CLRN1-AS1]]'' |
|- | |- | ||
|West Syndrome | |West Syndrome | ||
| − | |''LINC00581'' | + | |''[[LINC00581]]'' |
|} | |} | ||
Revision as of 13:56, 29 June 2017
| Disease | LncRNAs |
|---|---|
| Alzheimer's disease | SNHG3, LINC01616, LINC01080, BACE1-AS, BCYRN1, HAR1A, SOX2-OT, LINC01772 |
| dermatomyositis | 7SL |
| Down syndrome | DSCR4, DSCR8 |
| Duchenne muscular dystrophy | LINCMD1 |
| facioscapulohumeral muscular dystrophy | DBET |
| Huntington's disease | HAR1A, TUG1, MEG3, NOP14-AS1, HTT-AS, BDNF-AS, HAR1B |
| ischemic stroke | CDKN2B-AS1 |
| multiple sclerosis | IFNG-AS1 |
| myotonic dystrophy | DM1-AS |
| narcolepsy | LINC00165 |
| neural tube defects | H19 |
| neurodevelopmental syndromes | SOX2-OT |
| Parkinson's Disease | MAPT-AS1 |
| Prader-Willi syndrome | MKRN3-AS1, SNHG14, PWRN1, PWRN2, IPW, PWARSN, MKRN3-AS1, H19, MEG8 |
| psychiatric disease | BDNF-AS |
| spinocerebellar ataxia | SCAANT1, ATXN8OS |
| syndromic developmental defect | MIR17HG |
| Usher syndrome type 3 | CLRN1-AS1 |
| West Syndrome | LINC00581 |
